| 000 | 01128 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250518005715.0 | ||
| 264 | 0 | _c20200205 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/0929867325666181112091700 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Ting-Ting | |
| 245 | 0 | 0 |
_aIsoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2019 |
||
| 300 |
_a6786-6796 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aChalcones _xchemistry |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aXu, Yu-Qing | |
| 700 | 1 | _aHu, Hui-Min | |
| 700 | 1 | _aGong, Hai-Bin | |
| 700 | 1 | _aZhu, Hai-Liang | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 26 _gno. 37 _gp. 6786-6796 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/0929867325666181112091700 _zAvailable from publisher's website |
| 999 |
_c29033497 _d29033497 |
||